Newsletter

Stay up to date on all things IBS. Sign up and we’ll send you the latest news, resources, scientific breakthroughs, events, tips, and much more.

Make a comment and share this article on your profile.

Write a comment for your publication

Successfully Shared!

View on my Profile

Effect of Curcumin on Gut Microbiota in IBS

December 20, 2019

Overview

This study aims to investigate how the food supplement curcumin affects children with irritable bowel syndrome (IBS) in terms of changes in microbiota and symptom relief. Curcumin is a spice commonly used in Asian cooking and it will be administered in a capsule in this study to see if it can be used as a treatment for FGID (functional gastrointestinal disorders.)

 

Study Information

Participants will be placed into two groups: one will receive the treatment arm of 50 mg capsule of curcumin twice a day or three times a day (depending on the participant’s weight) for 8 weeks in a capsule. The second group will receive a placebo capsule of a similar size, shape, and color for 8 weeks. Investigators are looking for 50 participants. The study started on August 1, 2018 and is estimated to be completed by March 2020.

 

Inclusion Criteria

 

  • Ages 10-18 years
  • Fulfill the Rome IV criteria for diarrhea predominant IBS
  • English speaking
  • Able to swallow curcumin/placebo capsules

 

Exclusion Criteria

 

  • Weigh less than 35 kg
  • On any form of dietary restrictions
  • Taken probiotics one month before enrollment
  • Antibiotic treatment one month before enrollment
  • Any of the following: IBD, Celiac disease, Peptic ulcer disease, H. Pylori gastritis, Abnormality of gastrointestinal tract, Previous abnormal endoscope, Previous abdominal surgeries, Gallstones, Biliary tract obstructions, Liver pathologies, Liver failure, Active GI infection, Positive stool cultures, Drug or alcohol abuse
  • Concomitant immunological/hematological/neoplastic/heart/ renal/pulmonary condition
  • Any other medical condition or taking any form of drug(s) which can explain the current symptoms
  • Take oral or intravenous drugs which could have potential drug interaction with curcumin
  • Lactating or pregnant or planning to become pregnant
  • Developmental delay
  • Parents that are developmentally delayed
  • Have a diet high in curcumin/turmeric

 

Location

Medical College of Wisconsin

Milwaukee, Wisconsin, United States, 53226

Contact: Manu Sood, MD    414-266-3690 msood@mcw.edu

 

Sponsors/Collaborators

Medical College of Wisconsin

Clinical & Translational Science Institute of Southeast Wisconsin

Clinical Trials

View All Clinical Trials

Effect of Tai Chi as Treatment for IBS-C

This study investigates how effective the practice of Tai Chi is in reducing symptoms associated with irritable…

Psychological Therapies and Functional Bowel Disorders

This study aims to investigate how psychological therapies affect people with functional bowel disorders like…

Acceptability and Efficacy of the Zemedy App for IBS

This is a study that investigates whether the self-help app Zemedy is helpful for improving the quality of life of…

Vitamin D Supplementation in IBS

This trial investigates the effect of supplementing with Vitamin D on irritable bowel syndrome (IBS) symptoms for…

Efficacy and Safety of IBS Digital Behavioral Treatment

This study investigates the EASITx treatment for irritable bowel syndrome (IBS). The treatment is a medical device…

Fecal Metabolome and the Intestinal Microbiota in IBS

This study examines the relationship between fecal bile acids, SCFA, and gut microbiota in patients with irritable bowel syndrome (IBS). Through…

Send this to a friend